• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience

The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • expand A Phase IIA, Multi centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Effect of 8 Weeks Treatment with Oral AZD3241 on Microglia Activation, as Measured by Positron Emission Tomography (PET), in Patients with Parkinson’s Disease.
    Study Id
    D0490C00004
    Disease
    Parkinson's disease
    Drug Name
    AstraZeneca Neuroscience Development Drugs
    Study Name
    D0490C00004
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Objective assessment of metabolic monitoring in patients treated with Seroquel® or Seroquel® XR/quetiapine fumarate: use of IMS Disease Analyzer to assess physician behaviour in the UK and Germany
    Study Id
    D1443C00128
    Disease
    bipolar disorder, depressive disorder, schizophrenia
    Drug Name
    AstraZeneca Neuroscience Brands, non drug study (neuroscience)
    Study Name
    D1443C00128
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand European study in patients with osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis at gastrointestinal risk: A restrospective, non-internventional study of Vimovo™ prescribing patterns.
    Study Id
    D1120C00044
    Disease
    prescribing information
    Drug Name
    non drug study (neuroscience)
    Study Name
    CHARACTERIZE
    Recruiting Status
    Enrolling by invitation
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
    Study Id
    D144CC00005
    Disease
    bipolar disorder
    Drug Name
    Seroquel XR
    Study Name
    D144CC00005
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Open-Label 52-week Study to Assess the Long-Term Safety of NKTR-118 in Opioid-Induced Constipation (OIC) in Patients With Non-Cancer-Related Pain
    Study Id
    D3820C00008
    Study Name
    D3820C00008
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Open-Label Positron Emission Tomography Study with the Selective β Amyloid Radioligand [18F]AZD4694 to Assess the Effects of Varying Radioligand Mass on Binding Parameters in Healthy Volunteers and Patients with Alzheimer’s Disease
    Study Id
    D2750C00002
    Drug Name
    AZD4694
    Study Name
    D2750C00002
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative, Phase 4 Study
    Study Id
    D1443L00086
    Disease
    bipolar mania
    Drug Name
    Seroquel XR
    Study Name
    D1443L00086
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study
    Study Id
    NIS-NES-XXX-2011/3
    Disease
    depression
    Drug Name
    non drug study (neuroscience)
    Study Name
    NIS-NES-XXX-2011/3
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
    Study Id
    NIS-NES-DUM-2010/1
    Disease
    bipolar depression
    Drug Name
    non drug study (neuroscience)
    Study Name
    NIS-NES-DUM-2010/1
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Randomized, Double-Blind, Placebo-Controlled 12-Week Extension Study to Assess the Safety and Tolerability of NKTR-118 in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
    Study Id
    D3820C00007
    Disease
    pain
    Drug Name
    NKTR 118
    Study Name
    D3820C00007
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013